Keith A. Katkin

Keith A. Katkin's Title

Keith A. Katkin is an accomplished executive currently serving as the Chairman of the Board of Directors. His extensive experience in leadership roles across multiple pharmaceutical companies highlights his expertise and strategic vision in the industry. His career trajectory includes significant positions that have shaped his reputation as a leader and innovator in healthcare and pharmaceuticals.

Keith A. Katkin's Company

Keith A. Katkin has been instrumental in the growth and strategic direction of several companies. Notably, he served as Chairman of the Board of Directors for Otic Pharma from 2015 to 2017 and led Avanir Pharmaceuticals, Inc. as President and CEO from 2007 to 2016. At Avanir, he orchestrated the company's growth and eventual $3.5 billion sale to Otsuka Pharmaceutical Co., Ltd. Currently, he serves on the Board of Directors of Syndax Pharmaceuticals, Inc., and Emergent BioSolutions, Inc., contributing his expertise to these leading pharmaceutical companies.

Keith A. Katkin's Education and Expertise

Keith A. Katkin holds an M.B.A. from the Anderson School of Business at UCLA, complementing his B.S. in Business and Accounting from Indiana University. As a certified public accountant, his robust educational background provides a solid foundation for his strategic and financial acumen. His expertise spans commercial development, sales, and marketing, as evidenced by his leadership roles at Peninsula Pharmaceuticals, InterMune, Inc., Amgen, Inc., and Abbott Laboratories.

Keith A. Katkin's Achievements

Throughout his career, Keith A. Katkin has achieved significant milestones. His leadership at Avanir Pharmaceuticals led to the company's growth and a $3.5 billion acquisition by Otsuka Pharmaceutical Co., Ltd. He has also been a crucial member of various boards, including Urovant Sciences Ltd, Rigel Pharmaceuticals, and currently Syndax Pharmaceuticals, Inc., and Emergent BioSolutions, Inc. These roles underscore his ability to drive strategic initiatives and foster growth within the pharmaceutical industry.

Keith A. Katkin's Background

Keith A. Katkin's professional journey began in the pharmaceutical industry, where he has held numerous leadership roles. His early career included positions at Abbott Laboratories and Amgen, Inc., where he developed his expertise in commercial development and sales. He joined Avanir Pharmaceuticals in 2005 as Senior Vice President of Sales and Marketing, eventually becoming President and CEO. His tenure at various companies has been marked by strategic growth, successful mergers, and acquisitions, making him a respected figure in the industry.